Microscopic Polyangiitis
📧 Sign up to get email alerts when something new happens for Microscopic Polyangiitis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-08-21EMA Revoked: Tavneos (avacopan) — Vifor Fresenius Medical Care Renal Pharma France
The EMA revoked Tavneos (avacopan) for its indications, including Microscopic Polyangiitis and Wegener Granulomatosis, effective January 15,…
-
EMA withdrawal · 2026-08-19EMA Revoked: Tavneos (avacopan) — Vifor Fresenius Medical Care Renal Pharma France
The EMA revoked Tavneos (avacopan) authorization for indications including Microscopic Polyangiitis and Wegener Granulomatosis.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 4]
A Phase 4 clinical trial comparing clinico-biological monitoring to pre-emptive rituximab for ANCA reappearance in granulomatosis with polya…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA [Phase 2]
A Phase 2 clinical trial is evaluating rapcabtagene autoleucel for severe active granulomatosis with polyangiitis and microscopic polyangiit…
-
EMA trial_result · 2026-01-30EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA
The EMA has started a review of Tavneos (avacopan) after questions were raised about the integrity of data from the main pivotal study in gr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) [Phase 3]
The SAFE-LOW Phase 3 trial evaluating low-dose glucocorticoids for ANCA-associated vasculitis is currently recruiting, focusing on granuloma…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Vasculitis Pregnancy Registry
Clinical trial update for a pregnancy registry in vasculitis sponsored by the University of Pennsylvania, currently recruiting to evaluate p…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]
A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
A clinical trial update for the CUTIS study, which is recruiting to study transcriptomics in systemic vasculitis conditions.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: One-Time DNA Study for Vasculitis
A University of Pennsylvania-led trial is recruiting for a one-time DNA study of various vasculitides, including eosinophilic granulomatosis…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: VCRC Tissue Repository
The University of Pennsylvania–sponsored VCRC Tissue Repository trial is currently recruiting. It covers multiple forms of vasculitis.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator
A completed clinical trial comparing rituximab biosimilars to the originator in ANCA-associated vasculitis, including granulomatosis with po…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) [Phase 1]
Phase 1 clinical trial update for SC291 in severe B-cell–mediated autoimmune diseases; the study is active but not recruiting and includes s…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Efficacy Study of Two Treatments in the Remission of Vasculitis [Phase 3]
Phase 3 trial update evaluating two treatments for inducing remission in granulomatosis with polyangiitis and microscopic polyangiitis; the …
-
EMA approval · 2025-10-06EMA Authorised: Rixathon (rituximab) — Sandoz GmbH
EMA authorised Rixathon (rituximab) by Sandoz as a biosimilar to Rituxan for several autoimmune and hematologic diseases, expanding access t…
-
EMA approval · 2025-09-29EMA Authorised: Truxima (rituximab) — Celltrion Healthcare Hungary Kft.
EMA authorised Truxima (rituximab) by Celltrion Healthcare Hungary Kft. as a biosimilar rituximab for several indications including Non-Hodg…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) [Phase 3]
A Phase 3 trial evaluated adding azathioprine to corticosteroids in microscopic polyangiitis, polyarteritis nodosa, or eosinophilic granulom…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis [Phase 3]
Phase 3 trial comparing two rituximab regimens for maintaining or achieving remission in ANCA-associated vasculitis has completed.
-
EMA approval · 2025-08-05EMA Authorised: Riximyo (rituximab) — Sandoz GmbH
EMA authorized the biosimilar Riximyo (rituximab) by Sandoz GmbH for multiple indications, including Non-Hodgkin lymphoma, rheumatoid arthri…
-
EMA approval · 2025-07-14EMA Authorised: Ruxience (rituximab) — Pfizer Europe MA EEIG
The EMA authorised Ruxience, a rituximab biosimilar by Pfizer Europe MA EEIG, for several indications including chronic lymphocytic leukemia…
-
EMA approval · 2025-01-31EMA Authorised: Tavneos (avacopan) — Vifor Fresenius Medical Care Renal Pharma France
The European Medicines Agency authorised Tavneos (avacopan) for microscopic polyangiitis and granulomatosis with polyangiitis (Wegener's gra…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Special Drug Use-results Survey for Long-term Use（Avacopan）
A long-term-use results survey for avacopan in microscopic polyangiitis and granulomatosis with polyangiitis is currently recruiting in a st…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) [Phase 3]
Phase 3 trial evaluating mycophenolate mofetil for relapses of granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic p…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: PR3-AAV Resilient Remission or PRRR [Phase 2]
A Phase 2 trial of PR3-AAV Resilient Remission (PRRR) for ANCA-associated vasculitis, including granulomatosis with polyangiitis and microsc…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Hydroxychloroquine in ANCA Vasculitis Evaluation [Phase 4]
Phase 4 trial update evaluating hydroxychloroquine for ANCA-associated vasculitis, including microscopic polyangiitis, eosinophilic granulom…